What is Matter?
Founded in 2015, Matter operates on the principle that collaborative efforts are paramount to advancing healthcare. The organization brings together a global network of startups, alongside numerous hospitals, health systems, universities, and industry leaders. This ecosystem is designed to foster innovation, accelerate the adoption of new care methodologies, and ultimately enhance patient outcomes. Matter's approach focuses on creating a synergistic environment where diverse entities can co-create the future of healthcare.
How much funding has Matter raised?
Matter has raised a total of $39.4M across 2 funding rounds:
Unspecified
$4.4M
Series A
$35M
Unspecified (2014): $4.4M with participation from Astellas Pharma, Marathon Pharmaceuticals, LLC, and AbbVie Inc.
Series A (2022): $35M led by Jordan Park Group
Key Investors in Matter
Jordan Park Group
Jordan Park Group is an investment firm that has participated in Matter's funding rounds. Further details on their specific investment focus within healthcare are not publicly disclosed.
Astellas Pharma
Astellas Pharma is a global pharmaceutical company focused on developing and delivering innovative medicines. Their investment in Matter aligns with a strategy to foster healthcare innovation and improve patient outcomes through strategic partnerships.
AbbVie Inc.
AbbVie Inc. is a biopharmaceutical company dedicated to discovering and developing advanced therapies for complex medical challenges. Their backing of Matter highlights a commitment to collaborative innovation within the healthcare sector.
What's next for Matter?
The recent strategic investment signifies a critical growth phase for Matter, likely enabling the expansion of its collaborative network and the scaling of its innovation initiatives. With a strong foundation built on partnerships across the healthcare spectrum, Matter is well-positioned to address complex challenges and drive meaningful change. Future endeavors will likely focus on further integrating technology and data-driven solutions to optimize patient care pathways and foster a more efficient healthcare ecosystem.
See full Matter company page
